Neuroleptics antagonize nalbuphine antianalgesia

Journal of Pain

Volumn 7, Issue 3, 2006, Pages 187-191

  Gear, Robert W ^a   Lee, Janice S ^a   Miaskowski, Christine ^b   Gordon, Newton C ^a   Paul, Steven M ^a   Levine, Jon D ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Chlorpromazine; Gender; Haloperidol; Kappa opioid; Pain; Sexual dimorphism

Indexed keywords

CHLORPROMAZINE; HALOPERIDOL; NALBUPHINE;

ARTICLE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG EFFECT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLAR TOOTH; PAIN ASSESSMENT; POSTOPERATIVE PAIN; SEX DIFFERENCE; TOOTH DISEASE; TOOTH EXTRACTION;

ANALGESICS, OPIOID; CHLORPROMAZINE; DRUG THERAPY, COMBINATION; FEMALE; HALOPERIDOL; HUMANS; MALE; NALBUPHINE; PAIN MEASUREMENT; PAIN, POSTOPERATIVE; RECEPTORS, OPIOID; SEX FACTORS; TOOTH EXTRACTION;

EID: 33644637194     PISSN: 15265900     EISSN: 15288447     Source Type: Journal    
DOI: 10.1016/j.jpain.2005.10.005     Document Type: Article

References (29)

1. R.J. Baldessarini, F.I. Tarazi Drugs and the treatment of psychiatric disorders Psychosis and mania A.G. Gilman J.G. Hardman L.E. Limbird Goodman & Gilman's The Pharmacological Basis of Therapeutics 2001 McGraw-Hill New York, NY 485 520
2. C.C. Chien, G.W. Pasternak Functional antagonism of morphine analgesia by (+)-pentazocine Evidence for an anti-opioid sigma 1 system Eur J Pharmacol 250 1993 R7 R8
3. C.C. Chien, G.W. Pasternak Selective antagonism of opioid analgesia by a sigma system J Pharmacol Exp Ther 271 1994 1583 1590
4. S. Couture, G. Debonnel Some of the effects of the selective sigma ligand (+)pentazocine are mediated via a naloxone-sensitive receptor Synapse 39 2001 323 331
5. J.K. Errick, R.C. Heel Nalbuphine A preliminary review of its pharmacological properties and therapeutic efficacy Drugs 26 1983 191 211
6. J. Faucett, N. Gordon, J. Levine Differences in postoperative pain severity among four ethnic groups J Pain Symptom Manage 9 1994 383 389
7. R.B. Fillingim, R.W. Gear Sex differences in opioid analgesia Clinical and experimental findings Eur J Pain 8 2004 413 425
8. R.B. Fillingim, T.J. Ness, T.L. Glover, C.M. Campbell, D.D. Price, R. Staud Experimental pain models reveal no sex differences in pentazocine analgesia in humans Anesthesiology 100 2004 1263 1270
9. R.W. Gear, N.C. Gordon, P.H. Heller, S. Paul, C. Miaskowski, J.D. Levine Gender difference in analgesic response to the kappa-opioid pentazocine Neurosci Lett 205 1996 207 209
10. R.W. Gear, N.C. Gordon, C. Miaskowski, S.M. Paul, P.H. Heller, J.D. Levine Dose ratio is important in maximizing naloxone enhancement of nalbuphine analgesia in humans Neurosci Lett 351 2003 5 8
11. R.W. Gear, N.C. Gordon, C. Miaskowski, S.M. Paul, P.H. Heller, J.D. Levine Sexual dimorphism in very low dose nalbuphine postoperative analgesia Neurosci Lett 339 2003 1 4
12. R.W. Gear, C. Miaskowski, N.C. Gordon, S.M. Paul, P.H. Heller, J.D. Levine Kappa-opioids produce significantly greater analgesia in women than in men Nat Med 2 1996 1248 1250
13. R.W. Gear, C. Miaskowski, N.C. Gordon, S.M. Paul, P.H. Heller, J.D. Levine The kappa opioid nalbuphine produces gender- and dose-dependent analgesia and antianalgesia in patients with postoperative pain Pain 83 1999 339 345
14. R.W. Gear, C. Miaskowski, N.C. Gordon, S.M. Paul, P.H. Heller, J.D. Levine Action of naloxone on gender-dependent analgesic and anti-analgesic effects of nalbuphine in humans J Pain 1 2000 122 127
15. N.C. Gordon, R.W. Gear, P.H. Heller, S. Paul, C. Miaskowski, J.D. Levine Enhancement of morphine analgesia by the GABAB agonist baclofen Neuroscience 69 1995 345 349
16. H.B. Gutstein, H. Akil Opioid analgesics J.G. Hardman L.E. Limbird Goodman & Gilman's The Pharmacological Basis of Therapeutics 2001 McGraw-Hill New York, NY 569 619
17. J.D. Levine, N.C. Gordon Influence of the method of drug administration on analgesic response Nature 312 1984 755 756
18. J.D. Levine, N.C. Gordon, Y.O. Taiwo, T.J. Coderre Potentiation of pentazocine analgesia by low-dose naloxone J Clin Invest 82 1988 1574 1577
19. J.E. Leysen, W. Gommeren, J. Mertens, W.H. Luyten, P.J. Pauwels, M. Ewert, P. Seeburg Comparison of in vitro binding properties of a series of dopamine antagonists and agonists for cloned human dopamine D2S and D2L receptors and for D2 receptors in rat striatal and mesolimbic tissues, using [125I] 2'-iodospiperone Psychopharmacology (Berl) 110 1993 27 36
20. W.R. Martin, C.G. Eades, J.A. Thompson, R.E. Huppler, P.E. Gilbert The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog J Pharmacol Exp Ther 197 1976 517 532
21. R.R. Matsumoto, B. Pouw Correlation between neuroleptic binding to sigma(1) and sigma(2) receptors and acute dystonic reactions Eur J Pharmacol 401 2000 155 160
22. D.J. McCann, A.D. Weissman, T.P. Su Sigma-1 and sigma-2 sites in rat brain Comparison of regional, ontogenetic, and subcellular patterns Synapse 17 1994 182 189
23. R. Quirion, W.D. Bowen, Y. Itzhak, J.L. Junien, J.M. Musacchio, R.B. Rothman, T.P. Su, S.W. Tam, D.P. Taylor A proposal for the classification of sigma binding sites Trends Pharmacol Sci 13 1992 85 86
24. S. Takahashi, K. Sonehara, K. Takagi, T. Miwa, K. Horikomi, N. Mita, H. Nagase, K. Iizuka, K. Sakai Pharmacological profile of MS-377, a novel antipsychotic agent with selective affinity for sigma receptors Psychopharmacology (Berl) 145 1999 295 302
25. S.W. Tam Naloxone-inaccessible sigma receptor in rat central nervous system Proc Natl Acad Sci U S A 80 1983 6703 6707
26. S.W. Tam, L. Cook Sigma opiates and certain antipsychotic drugs mutually inhibit (+)-[3H] SKF 10,047 and [3H]haloperidol binding in guinea pig brain membranes Proc Natl Acad Sci U S A 81 1984 5618 5621
27. M. Terai, S. Usuda, I. Kuroiwa, O. Noshiro, H. Maeno Selective binding of YM-09151-2, a new potent neuroleptic, to D2-dopaminergic receptors Jpn J Pharmacol 33 1983 749 755
28. L.I. Tsao, T.P. Su Naloxone-sensitive, haloperidol-sensitive, [3H](+)SKF-10047-binding protein partially purified from rat liver and rat brain membranes An opioid/sigma receptor? Synapse 25 1997 117 124
29. J. Zhu, L.Y. Luo, J.G. Li, C. Chen, L.Y. Liu-Chen Activation of the cloned human kappa opioid receptor by agonists enhances [35S]GTPgammaS binding to membranes Determination of potencies and efficacies of ligands J Pharmacol Exp Ther 282 1997 676 684